NCT05226169 2026-04-03
Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)
Asan Medical Center
Phase 3 Recruiting
Clinical Trials
10 trialsNCT05744219 2024-10-21
IRIS
Uppsala University Hospital
Phase 3 Recruiting
NCT04653181 2024-02-29
PREFECO
Helsinki University Central Hospital
Phase NA Unknown
NCT02469480 2020-10-19
Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study.
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2 Completed
NCT02628860 2020-04-28
FCM
National Cancer Center, Korea
Phase 2 Completed
NCT02949947 2020-04-06
Efficacy of Ferric Carboxymaltose in Gastrointestinal Stromal Tumor (GIST) Patients With Iron Deficiency Anemia (IDA) Receiving Systemic Therapy
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT04168346 2019-11-19
IRONSTOMACH
Helsinki University Central Hospital
Phase 4 Not yet recruiting
NCT02243735 2018-08-28
FIT
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 4 Unknown
NCT01701310 2016-10-28
IVICA
Nottingham University Hospitals NHS Trust
Phase 4 Completed
NCT02057471 2014-02-07
Intravenous Iron: Measuring Response in Anemic Surgical Patients
Nottingham University Hospitals NHS Trust
Phase 4 Completed